Skip to content

A Phase 1 Study to Investigate the Effect of Food on the Bioavailability of a Single Cytisinicline 3 mg Tablet and Evaluation of the Pharmacokinetics of Multiple 3 mg Doses (Three Times Daily) in Healthy Adult Smokers

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504260-42-00
Acronym
ACH-CYT-11
Enrollment
30
Registered
2023-07-26
Start date
2023-08-08
Completion date
2023-09-21
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition

Interventions

None listed

Sponsors

Achieve Life Sciences Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026